Acamprosate for the treatment of alcohol dependence: A review of double-blind, placebo-controlled trials

CNS Spectrums

Volumn 5, Issue 2, 2000, Pages 58-69

  Mason, Barbara J ^a   Ownby, Raymond L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACAMPROSATE; ALCOHOL; DISULFIRAM; GAMMA GLUTAMYLTRANSFERASE; HOMOTAURINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PLACEBO;

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLISM; CLINICAL TRIAL; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; REVIEW;

EID: 0033981628     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1092852900012827     Document Type: Article

References (32)

1. Hunt WA. Neuroscience research: how has it contributed to our understanding of alcohol abuse and alcoholism? A review. Alcohol Clin Exp Res. 1993;17:1055-1065.
2. Borg S. Biochemical and clinical features in alcoholic patients during long term abstinence and prior to relapse [abstract]. Alcohol Alcohol 1988;23:515-525.
3. Rassnick S, D'Amico E, Riley E, Pulvirenti L GABA and nucleus accumbens glutamate neurotransmission modulate ethanol self-administration in rats. Ann NY Acad Sci. 1992;654:502-505
4. Lamblin F, Deuceuninck D, DeWitte PH. Modulation of alcohol preference by NMDA antagonists in male rats. Alcohol Alcohol 1993;28:639-647.
5. Zeise ML, Kasparow S, Capogna M, Zieglgansberger W. Acamprosate (calcium homotaurinate) decreases postsynaptic potentials in the rat neocortex: possible involvement of excitatory amino acid receptors. Eur J Pharmacol. 1993;231:47-52.
6. Alquatari M, Littleton J. The anticraving drug acamprosate inhibits calcium channel antagonist binding to membranes from the rat cerebral cortex [abstract]. Alcohol Alcohol. 1995;30:551.
7. Naasila M, Hammoumi S, Legrand E, Durbin P, Daoust M. Mechanism of. action of acamprosate. Part 1. Characterization of spermidine-sensitive acamprosate binding site in rat brain. Alcohol Clin Exp Res. 1998-2:1-8.
8. Boismare F, Daoust M, Moore N, et al. A homotaurinate derivative reduces the voluntary ethanol intake by rats: are cerebral GABA receptors involved? Pharmacol Biochem Behav. 1984;21:787-789.
9. Le Magnen J, Tran G, Durlach J. Lack of effects of Caacetyl homotaurinate on chronic and acute toxicities of ethanol in rats. Alcohol. 1987;4:103-108.
10. Gewiss M, Heidbreder CH, Opsomer L, Durbin PH, DeWitte PH. Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour. Alcohol Alcohol. 1991;26:129-137.
11. Grant KA, Woolverton WL. Reinforcing and discriminative effects of acetylhomotaurine in animals. Pharmacol Biochem Behav. 1989;32:607-611.
12. Durbin P, Hulot T, Chabac S. Pharmacodynamics and pharmacokinetics of acamprosate: an overview. In: Soyka M, ed. Acamprosate in Relapse Prevention of Alcoholism. Berlin, Germany: Springer Verlag; 19%.
13. Mason BH, Goodman AM. Cognitm effects ofnaltrexone and acamprosate administered alone and in combination. Presented at Annual Meeting of the Research Society on Alcoholism (RSA); [June 27-July 1,1999] 1999; Santa Barbara, Calif.
14. Wilde MI, Wagstaff AJ. Acamprosate: a review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification. Drugs. 1997;53:1038-1053.
15. Lhuintre JP, Daoust M, Moore ND, et al. Ability of calcium acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics. Lancet. 1985;1:1014-1016.
16. Lhuintre JP, Moore ND, Tran G, et al. Acamprosate appears to decrease alcohol intake in weaned alcoholics. Alcohol Alcohol. 1990;25:613-622.
17. Pelc I, Le Bon 0, Verbanck P, Lehert PH, Opsomer L. Calcium acetyl homotaurinate for maintaining abstinence in weaned alcoholic patients; a placebo controlled double-blind multi-centre study. In: Naranjo C, Sellers E, eds. Novel Pharmacological Interventions for Alcoholism. New York, NY: Springer Verlag; 1992:348-352.
18. Ladewig D, Knecht T, Lehert P, et al. Acamprosate - a stabilizing factor in the long-term treatment of alcoholics. Ther Umsch. 1993;50:182-188.
19. Whitworth A, Fischer F, Lesch OM, et al. Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet. 1996;347:1438-1442.
20. Barrias JA, Chabac S, Ferreira L, Fonte A, Potgieter AS, Teixeira de Sousa E. Acamprosate: multicenter Portuguese efficacy and tolerance evaluation study. Psiquiatria Clinica 1997;18:149-160.
21. Poldrugo F. Acamprosate treatment in a long-term community-based alcohol rehabilitation programme. Addiction. 1997;92:1537-1546.
22. Besson J, Aeby F, Kasas A, Lehert P, Potgieter A. , Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: a controlled study. Alcohol Clin Exp Res. 1998;22:573-579.
23. Rousseaux JP, Hers D, Ferauge M. Does acamprosate diminish the appetite for alcohol in weaned alcoholics? JPharmBelg. 1996;51:65-68.
24. Sass H, Soyka M, Mann K, Zieglgansberger W. Relapse prevention by acamprosate: results from a placebo-controlled study on alcohol dependence. Arch Gen Psychiatry. 1996;53:673-680.
25. Geerlings, PJ, Ansoms C, van den Brink W. Acamprosate and prevention of relapse in alcoholics. European Addiction Research. 1997;3:129-137.
26. Paille F, Guelfi JD, Perkins AC, Royer RJ, Stem L, Parot P. Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. Alcohol Alcohol. 1995;30:239-247.
27. Pelc I, Verbanck P, Le Bon 0, Gavrilovic M, Lion K, Lehert P. Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependence patients: a 90day placebo-controlled dose-finding study. Br ] Psychiatry. 1997;171:73-77.
28. Chick J, Hewlett H, Morgan MY, Ritson B. United Kingdom multicentre acamprosate study (UKMAS): a 6 month prospective study of acamprosate vs placebo in preventing relapse after withdrawal from alcohol. Alcohol Alcohol In press.
29. Tempesta E, Janiri L, Bignamini A, Chabac S, Potgieter A. Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study. Alcohol Alcohol. In press.
30. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987.
31. Mason BJ, Goodman AM, Koob GF. Methodology of the US multicenter study of acamprosate in alcohol dependence. Presented at the American College of Neuropsychopharmacology (ACNP) Annual Meeting, Kamuela, Hawaii. 1997.
32. Mason BJ, Goodman AM. Brief Intervention and Medication Compliance Procedures Therapist's Manual. New York, NY: Lipha Pharmaceutical, Inc.; 1997.